Developer docs
API playgroundTry for free, no card

Search company profiles

MD Start

Full company profile

uuid0006tnb

Namestring
MD Start
Legal namestring
MD Start
Websiteurl
mdstart.eu
Company typeenum
Private
Founded yearint
2010
Descriptiontext

MD Start is a Paris-based medtech company builder structured as a 3-in-1 accelerator combining a seed fund, an incubator, and an in-house operating team. Founded in 2010 (per company legal notice) with a Sofinnova Partners-affiliated management structure since 2019, the firm sources proprietary deal flow from European physician and researcher inventors, screens over 1,400 invention submissions, and has created and financed 13 medical device companies across cardiovascular (CorWave, LimFlow, preCARDIA, Tulyp Medical, Julier Medical), surgical (Moon Surgical, SafeHeal, Endoron Medical), diagnostic (BrightHeart, APD), and interventional (HEPTA Medical, Gradient Denervation Technologies, May Health) domains. The portfolio spans technologies including LVADs with oscillating-membrane architecture, venous arterialization for critical limb ischemia, AI-driven prenatal ultrasound guidance, sensor-embedded ablation catheters, catheter-based endograft stapling, and a computer-vision/haptics robotic surgery platform.

MD Start operates a capital-efficient model where the partners themselves serve as founding CEOs or board directors of portfolio companies, providing hands-on operational support from idea screening through proof-of-concept, clinical trials, regulatory certification, and exit. The firm's fund syndicate for MD Start III includes Sofinnova Partners as manager alongside strategic LPs Bpifrance, Medtronic, LivaNova, the European Investment Fund, and Baxter Healthcare Corporation, with Medtronic also providing deal-flow referrals through its Eureka program. Revenue mechanics are typical of a venture fund — management fees on committed capital plus carried interest on exits — with no consumer-facing pricing.

The company has produced one confirmed strategic exit to date: APD (Advanced Perfusion Diagnostics) was acquired by Vygon in 2019 after CE marking its microcirculation monitoring device. Portfolio company CoreValve, advised by MD Start co-founder Mano Iyer, was sold to Medtronic for $800M (an advisor-level outcome rather than a direct MD Start exit). MD Start has referenced an MD Start IV fund, indicating continuation of the fund-series model.

Short descriptiontext

MD Start is a Paris-based medtech company builder and seed fund, operating a 3-in-1 accelerator structure (fund + incubator + operator team) that sources inventions from European physician and researcher inventors and has created 13 medical device companies across cardiovascular, surgical, diagnostic, and interventional domains, with the Sofinnova MD Start III fund managed by Sofinnova Partners.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersParis, France
HQ citystring
Paris
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medtech accelerator, medical device incubation, medtech venture building, seed fund management, company builder services
Industry2 codes
PRIMARYFSANAAAA
Early-Stage Venture Capital (Pre-Seed/Seed)
SECONDARYFSANAAAM
Accelerators & Incubators (Investor-Operated)
NAICS code1 code
  • Open-End Investment Funds525910
Product category
Medtech Company Building Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Seed Fund / Accelerator Management
TypeManaged Services
Description

MD Start operates as a seed fund and incubator that creates, develops, and operates medtech projects from ideation through to investment stage and commercial development. Revenue is generated through fund management fees and carried interest from portfolio company exits.

mdstart.eu
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

MD Start is a medtech company builder operating as a seed fund, incubator, and operator team within a single 3-in-1 accelerator structure. It sources inventions from physician and researcher inventors, evaluates them through a structured non-confidential process, and creates, develops, and operates portfolio companies in cardiovascular, surgical, diagnostic, and interventional medical device domains until they reach investment stage and commercial development. The latest fund, Sofinnova MD Start III, has built six new companies.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Over 1400 inventions evaluated since 2010
+2 more records
Product overview1 text field

MD Start is a medtech company builder that operates as a seed fund, incubator, and accelerator for medical technologies. Rather than offering a unified software product or platform, MD Start creates, develops, and operates medical device portfolio companies, turning ideas into new companies with strategic and hands-on approaches to bring them to investment stage and commercial development. The portfolio spans 13 medical device companies across diverse therapeutic areas including cardiac assist (CorWave), stroke treatment (Julier Medical), prenatal screening (BrightHeart), limb ischemia (Tulyp Medical, LimFlow), surgical robotics (Moon Surgical), lung cancer treatment (HEPTA Medical), heart failure (preCARDIA), PCOS treatment (May Health), colorectal surgery (SafeHeal), vascular repair (Endoron Medical), and pulmonary hypertension (Gradient Denervation Technologies).

Product and service1 record
1BrightHeart
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
1ISIR (Institut des Systèmes Intelligents et de Robotique) / Sorbonne University
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Moon Surgical was initiated based on technology and IP developed at ISIR (Institut des Systèmes Intelligents et de Robotique), part of Sorbonne University in Paris, together with Pr. Brice Gayet, a world-renowned digestive surgeon and pioneer in laparoscopy.

mdstart.eu
2Prof. Ron Karmeli / Hadassah Hospital Jerusalem
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Endoron Medical builds on an invention from Prof. Ron Karmeli of Hadassah Hospital Jerusalem, who is co-founder and Chief Medical Officer of the company. Prof. Karmeli's invention forms the basis of the company's endograft stapling solution.

mdstart.eu
Strategic tierMinorTypeOthers
Description

Gérard Hascoët, Venture Partner at MD Start, serves as Chairman of EOS Imaging (France), a medical imaging technology company.

Strategic tierMinorTypeOthers
Description

Gérard Hascoët, Venture Partner at MD Start, serves as Director of the Board of CorWave (France), an MD Start portfolio company developing implantable blood pumps.

Strategic tierMinorTypeOthers
Description

Gérard Hascoët, Venture Partner at MD Start, serves as Director of the Board of SafeHeal (France), an MD Start portfolio company.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

JLABS is Johnson & Johnson's no-strings-attached healthcare incubator network operating across multiple geographies including Europe. It is a broad incumbent comparable providing early-stage medtech infrastructure, though at much larger scale and as part of a major strategic's broader innovation portfolio.

TypeDirect peer
Description

InCube Labs is a Silicon Valley-based life sciences incubator founded by Mir Imran that creates, develops, and spins out medical device companies. It is a direct peer as a multi-vertical medtech venture studio with hands-on operating model similar to MD Start.

TypeDirect peer
Description

Jeito Capital is a European life sciences investment firm focused on single-asset biotech and medtech opportunities. It is a direct peer as a specialized European healthcare investor with a similar thesis around backing differentiated science and technology from European innovators.

TypeDirect peer
Description

ExploraMed is a medical device incubator founded by Mir Imran that creates multiple medtech ventures from physician-sourced innovations. It is a direct peer in the company-building / venture studio model applied specifically to medical devices.

TypeOthers
Description

Bpifrance is the French public investment bank and a returning LP in MD Start III. It is thematically related as a capital partner in the European medtech ecosystem and co-invests across the same portfolio companies, though its primary role is as a financial backer rather than a direct operator/competitor.

TypeDirect peer
Description

Forbion is a leading European life sciences venture capital firm investing across biotech and medtech. It is a direct peer in European early-stage life sciences investing and frequently co-invests with strategic partners similar to MD Start's syndicate.

TypeDirect peer
Description

Sofinnova Partners is the parent platform that manages MD Start III and is a leading European life sciences venture capital firm. It is a direct peer in early-stage European medtech investing and is the most direct comparable given the operational integration with MD Start.

8MEDX Ventures
TypeDirect peer
Description

MEDX Ventures is a medical device-focused venture builder and incubator that creates and develops multiple startups in the medtech space. It is a direct peer operating a comparable multi-company medtech incubation model.

TypeDirect peer
Description

Lightstone Ventures is a venture capital firm focused on early-stage medtech and digital health investments, with strong European and US presence. It is a direct peer in early-stage, hands-on medtech venture investing with comparable therapeutic focus areas.

TypeDirect peer
Description

NLC Health is a European healthtech venture builder that creates and incubates multiple healthcare startups from a single platform, mirroring MD Start's company-building model. It is directly comparable as a venture studio operating in the European healthcare innovation ecosystem.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks1 record

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature13 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment4 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

MD Start

Medtech Company Building Servicesmdstart.eu

MD Start is a Paris-based medtech company builder and seed fund, operating a 3-in-1 accelerator structure (fund + incubator + operator team) that sources inventions from European physician and researcher inventors and has created 13 medical device companies across cardiovascular, surgical, diagnostic, and interventional domains, with the Sofinnova MD Start III fund managed by Sofinnova Partners.

What MD Start does

MD Start is a Paris-based medtech company builder structured as a 3-in-1 accelerator combining a seed fund, an incubator, and an in-house operating team. Founded in 2010 (per company legal notice) with a Sofinnova Partners-affiliated management structure since 2019, the firm sources proprietary deal flow from European physician and researcher inventors, screens over 1,400 invention submissions, and has created and financed 13 medical device companies across cardiovascular (CorWave, LimFlow, preCARDIA, Tulyp Medical, Julier Medical), surgical (Moon Surgical, SafeHeal, Endoron Medical), diagnostic (BrightHeart, APD), and interventional (HEPTA Medical, Gradient Denervation Technologies, May Health) domains. The portfolio spans technologies including LVADs with oscillating-membrane architecture, venous arterialization for critical limb ischemia, AI-driven prenatal ultrasound guidance, sensor-embedded ablation catheters, catheter-based endograft stapling, and a computer-vision/haptics robotic surgery platform.

MD Start operates a capital-efficient model where the partners themselves serve as founding CEOs or board directors of portfolio companies, providing hands-on operational support from idea screening through proof-of-concept, clinical trials, regulatory certification, and exit. The firm's fund syndicate for MD Start III includes Sofinnova Partners as manager alongside strategic LPs Bpifrance, Medtronic, LivaNova, the European Investment Fund, and Baxter Healthcare Corporation, with Medtronic also providing deal-flow referrals through its Eureka program. Revenue mechanics are typical of a venture fund — management fees on committed capital plus carried interest on exits — with no consumer-facing pricing.

The company has produced one confirmed strategic exit to date: APD (Advanced Perfusion Diagnostics) was acquired by Vygon in 2019 after CE marking its microcirculation monitoring device. Portfolio company CoreValve, advised by MD Start co-founder Mano Iyer, was sold to Medtronic for $800M (an advisor-level outcome rather than a direct MD Start exit). MD Start has referenced an MD Start IV fund, indicating continuation of the fund-series model.

MD Start firmographics

Firmographics
Name
MD Start
Legal name
MD Start
Website
https://mdstart.eu
Company type
Private
Founded year
2010
Operating status
Operating
Headcount range
1–10 employees
Short description
MD Start is a Paris-based medtech company builder and seed fund, operating a 3-in-1 accelerator structure (fund + incubator + operator team) that sources inventions from European physician and researcher inventors and has created 13 medical device companies across cardiovascular, surgical, diagnostic, and interventional domains, with the Sofinnova MD Start III fund managed by Sofinnova Partners.
Ownership category
akta.pro rank

MD Start industry classification

Industry
Product category
Medtech Company Building Services
NAICS
Open-End Investment Funds (525910)
akta.pro industry
PRIMARYFSANAAAA
Early-Stage Venture Capital (Pre-Seed/Seed)
SECONDARYFSANAAAM
Accelerators & Incubators (Investor-Operated)

Keywords

  • Medtech accelerator
  • Medical device incubation
  • Medtech venture building
  • Seed fund management
  • Company builder services

Where MD Start is headquartered

Location

Headquarters

HQ city
Paris
HQ country
France
HQ region
Europe

Offices1 record

Markets served

MD Start business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Seed Fund / Accelerator Management: MD Start operates as a seed fund and incubator that creates, develops, and operates medtech projects from ideation through to investment stage and commercial development. Revenue is generated through fund management fees and carried interest from portfolio company exits.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

MD Start product offering

Product offering

Core offering

MD Start is a medtech company builder operating as a seed fund, incubator, and operator team within a single 3-in-1 accelerator structure. It sources inventions from physician and researcher inventors, evaluates them through a structured non-confidential process, and creates, develops, and operates portfolio companies in cardiovascular, surgical, diagnostic, and interventional medical device domains until they reach investment stage and commercial development. The latest fund, Sofinnova MD Start III, has built six new companies.

Product overview

MD Start is a medtech company builder that operates as a seed fund, incubator, and accelerator for medical technologies. Rather than offering a unified software product or platform, MD Start creates, develops, and operates medical device portfolio companies, turning ideas into new companies with strategic and hands-on approaches to bring them to investment stage and commercial development. The portfolio spans 13 medical device companies across diverse therapeutic areas including cardiac assist (CorWave), stroke treatment (Julier Medical), prenatal screening (BrightHeart), limb ischemia (Tulyp Medical, LimFlow), surgical robotics (Moon Surgical), lung cancer treatment (HEPTA Medical), heart failure (preCARDIA), PCOS treatment (May Health), colorectal surgery (SafeHeal), vascular repair (Endoron Medical), and pulmonary hypertension (Gradient Denervation Technologies).

Differentiator

Problem solved

Functional benefit

Products and services

  • BrightHeart

Quantifiable outcome

  • Over 1400 inventions evaluated since 2010
  • +2 more outcomes

Companies that use MD Start

Customer profile

Named customers3 records

Segments2 records

Ideal customer profiles2 records

MD Start technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature13 records

MD Start partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and minor.

  • ISIR (Institut des Systèmes Intelligents et de Robotique) / Sorbonne UniversitycoreStrategic or Co-development PartnerMoon Surgical was initiated based on technology and IP developed at ISIR (Institut des Systèmes Intelligents et de Robotique), part of Sorbonne University in Paris, together with Pr. Brice Gayet, a world-renowned digestive surgeon and pioneer in laparoscopy.
  • Prof. Ron Karmeli / Hadassah Hospital JerusalemcoreStrategic or Co-development PartnerEndoron Medical builds on an invention from Prof. Ron Karmeli of Hadassah Hospital Jerusalem, who is co-founder and Chief Medical Officer of the company. Prof. Karmeli's invention forms the basis of the company's endograft stapling solution.
  • EOS ImagingminorOthersGérard Hascoët, Venture Partner at MD Start, serves as Chairman of EOS Imaging (France), a medical imaging technology company.
  • CorWaveminorOthersGérard Hascoët, Venture Partner at MD Start, serves as Director of the Board of CorWave (France), an MD Start portfolio company developing implantable blood pumps.
  • SafeHealminorOthersGérard Hascoët, Venture Partner at MD Start, serves as Director of the Board of SafeHeal (France), an MD Start portfolio company.

Scale indicators5 records

Recent moves7 records

Expansion highlights6 records

MD Start competitors and assessment

Company assessment

Broad incumbents

  • JLABS (Johnson & Johnson Innovation): JLABS is Johnson & Johnson's no-strings-attached healthcare incubator network operating across multiple geographies including Europe. It is a broad incumbent comparable providing early-stage medtech infrastructure, though at much larger scale and as part of a major strategic's broader innovation portfolio.

Direct peers

  • InCube Labs: InCube Labs is a Silicon Valley-based life sciences incubator founded by Mir Imran that creates, develops, and spins out medical device companies. It is a direct peer as a multi-vertical medtech venture studio with hands-on operating model similar to MD Start.
  • Jeito Capital: Jeito Capital is a European life sciences investment firm focused on single-asset biotech and medtech opportunities. It is a direct peer as a specialized European healthcare investor with a similar thesis around backing differentiated science and technology from European innovators.
  • ExploraMed: ExploraMed is a medical device incubator founded by Mir Imran that creates multiple medtech ventures from physician-sourced innovations. It is a direct peer in the company-building / venture studio model applied specifically to medical devices.
  • Forbion: Forbion is a leading European life sciences venture capital firm investing across biotech and medtech. It is a direct peer in European early-stage life sciences investing and frequently co-invests with strategic partners similar to MD Start's syndicate.
  • Sofinnova Partners: Sofinnova Partners is the parent platform that manages MD Start III and is a leading European life sciences venture capital firm. It is a direct peer in early-stage European medtech investing and is the most direct comparable given the operational integration with MD Start.
  • MEDX Ventures: MEDX Ventures is a medical device-focused venture builder and incubator that creates and develops multiple startups in the medtech space. It is a direct peer operating a comparable multi-company medtech incubation model.
  • Lightstone Ventures: Lightstone Ventures is a venture capital firm focused on early-stage medtech and digital health investments, with strong European and US presence. It is a direct peer in early-stage, hands-on medtech venture investing with comparable therapeutic focus areas.
  • NLC Health: NLC Health is a European healthtech venture builder that creates and incubates multiple healthcare startups from a single platform, mirroring MD Start's company-building model. It is directly comparable as a venture studio operating in the European healthcare innovation ecosystem.

Others

  • Bpifrance: Bpifrance is the French public investment bank and a returning LP in MD Start III. It is thematically related as a capital partner in the European medtech ecosystem and co-invests across the same portfolio companies, though its primary role is as a financial backer rather than a direct operator/competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks1 record

Key highlights6 records

Customer concentration

MD Start social profiles

Digital presence

MD Start financial estimates

Financial estimate

Revenue estimate

Valuation estimate

MD Start leadership team

Management profile

Number of profiles

Profiles5 records

MD Start funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

MD Start M&A and investment

M&A and investment

M&A

Investments4 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MD Start

What does MD Start do?

MD Start is a medtech company builder operating as a seed fund, incubator, and operator team within a single 3-in-1 accelerator structure. It sources inventions from physician and researcher inventors, evaluates them through a structured non-confidential process, and creates, develops, and operates portfolio companies in cardiovascular, surgical, diagnostic, and interventional medical device domains until they reach investment stage and commercial development. The latest fund, Sofinnova MD Start III, has built six new companies.

Is MD Start a public or private company?

MD Start is a private company. It is classified as venture growth investor backed and is currently operating.

When was MD Start founded?

MD Start was founded in 2010. It employs 1 to 10 people.

Where is MD Start based?

MD Start is headquartered in Paris, France, in the Europe region.

How does MD Start make money?

One revenue line is on record: seed Fund / Accelerator Management.

Who are MD Start's main competitors?

JLABS (Johnson & Johnson Innovation) is listed as a broad incumbent. Direct peers are InCube Labs, Jeito Capital, ExploraMed, Forbion, Sofinnova Partners, MEDX Ventures, Lightstone Ventures and NLC Health. Bpifrance is listed as an others.

Does MD Start have an API?

No public API is recorded for MD Start.

What industry is MD Start in?

MD Start's product category is Medtech Company Building Services. Its primary akta.pro industry code is FSANAAAA, Early-Stage Venture Capital (Pre-Seed/Seed), with a secondary code of FSANAAAM, Accelerators & Incubators (Investor-Operated). Its NAICS code is 525910.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Labiotech.euVCs and universities: How tech transfer strengthens collaborationEuropean university spinouts in life sciences are valued at $398 billion, but universities and venture capitalists often struggle to collaborate due to differing goals and timelines. Experts note that tech transfer offices can bridge this gap, though funding remains a concern, with biopharma funding down 20% last year.PharmiWeb.comTulyp Medical emerges from Sofinnova’s medtech accelerator and announces FDA submission following initial first-in-human useTulyp Medical, a Paris-based medtech startup backed by Sofinnova MD Start, emerged from stealth and submitted its 510(k) application to the U.S. FDA for a pressure-driven perfusion device designed to maintain healthy blood flow during vascular procedures. The submission follows positive first-in-human results demonstrating safety and functionality of the patented technology, which controls pressure rather than flow to optimize oxygen delivery. The company, led by medtech entrepreneurs including former preCARDIA co-founders, aims to reduce complications such as amputations and death in procedures requiring tissue oxygenation.SofinnovapartnersSofinnova MD Start III announces first two medtech investments — Sofinnova PartnersSofinnova Partners announced its second investment in MastOR, a French surgical robotics company, and its first in Gradient Denervation Technologies, a pulmonary hypertension device developer. The MD Start III fund, raised €48 million in May 2019, has made two seed investments so far.FinSMEsSorin Group and Versant Ventures Join MD Start as ShareholdersMD Start, a Lausanne-based medical device incubator, added Sorin Group and Versant Ventures as shareholders. The incubator, founded by Tim Lenihan and Gérard Hascoët, aims to accelerate European medical device development. It previously partnered with Medtronic to identify early-stage technologies.